Defunct Company
Total Trials
20
As Lead Sponsor
13
As Collaborator
7
Total Enrollment
4,750
NCT01146860
Efficacy and Safety of a Herbal Medicinal Product (Dry Extract BNO 1016) in Patients With Acute Rhinosinusitis
Phase: Phase 3
Role: Lead Sponsor
Start: Jan 31, 2010
Completion: Apr 30, 2010
NCT01309113
Dose-dependent Effects of VAC BNO 1095 on Cyclic Mastodynia and Premenstrual Syndrome
Start: Mar 31, 2011
Completion: Nov 30, 2012
NCT01478620
Safety and Efficacy of Canephron® N in the Management of Uncomplicated Urinary Tract Infections (uUTI)
Start: Oct 31, 2011
Completion: Aug 31, 2012
NCT01706484
Efficacy and Safety of Two Dosages of a Herbal Medicinal Product (Dry Extract BNO 1016) in Chronic Rhinosinusitis
Start: Sep 30, 2012
Completion: Jul 31, 2014
NCT01870687
Efficacy and Safety of 20 mg (2 Tablets of 10mg)VAC BNO 1095 FCT on Cyclic Mastodynia and PMS
Start: Jun 30, 2013
Completion: Oct 31, 2014
NCT01928901
Trial With Bronchipret and Sinupret to Evaluate Acceleration of Mucociliary Clearance (MCC)
Phase: Phase 2
Start: Aug 31, 2013
Completion: Feb 28, 2014
NCT02639520
Efficacy of CLR Compared to Fosfomycin Trometamol in Acute Lower uUTIs
Start: Dec 31, 2015
Completion: Jun 29, 2017
NCT02746042
Sinupret Extract Coated Tablets in Chronic Rhinosinusitis
Start: Apr 28, 2016
Completion: Aug 23, 2017
NCT04147273
Determination of Postprandial Glycemic Responses by Continuous Glucose Monitoring in a Real-World Setting
Phase: N/A
Role: Collaborator
Start: Dec 1, 2018
Completion: May 31, 2019
NCT03756974
BX-1 in Spasticity Due to Multiple Sclerosis
Start: Feb 18, 2019
Completion: Mar 30, 2021
NCT04537819
Study of Imupret Application in the Technology of Delayed Prescription of Antibiotics in Patients With Acute Tonsillitis
Start: Mar 20, 2019
Completion: Mar 25, 2020
NCT03984214
Efficacy and Safety of Dronabinol in the Improvement of Chemotherapy-induced and Tumor-related Symptoms in Advanced Pancreatic Cancer
Start: Dec 16, 2019
Completion: Sep 25, 2024
NCT04498013
Study of the Effects of Cyclodynon on Reducing the Cumulative Risk of Breast Cancer Development in a Female Aged 40-52
Phase: Phase 4
Start: Jul 22, 2020
Completion: May 1, 2022
NCT04448808
Treating Nightmares in Posttraumatic Stress Disorder With Dronabinol
Start: Oct 1, 2020
Completion: Jan 2, 2025
NCT05144217
Impact of Silymarin Dosages to Decrease Drug-induced Elevated Liver Enzymes Compared to Placebo
Phase: Phase 2/3
Start: Jun 23, 2021
Completion: Dec 31, 2024
NCT05786976
Assessment of Skin Tolerance and Efficacy of a Cosmetic Product After 4 Weeks of Use on Subjects With Atopic Dermatitis
Start: Jan 11, 2022
Completion: Feb 9, 2022
NCT05276375
Effect of Bronchipret on Antiviral Immune Response in Patients With Mild COVID-19
Start: Jan 14, 2022
Completion: Jun 30, 2023
NCT05807113
Assessment of Skin Tolerance and Efficacy of a Cosmetic Product After 5 Days of Use on Subjects With Atopic Dermatitis
Start: Feb 15, 2022
Completion: Feb 22, 2022
NCT05790083
Skin Efficacy and Tolerability of a Cosmetic Product Combination Over 3 Months in Subjects With Atopic Eczema
Start: Jan 3, 2023
Completion: Mar 30, 2023
NCT06211049
Efficacy of Vitex Agnus-castus BNO 1095 (20 mg) in Women With Primary Dysmenorrhea
Start: Dec 12, 2023
Completion: Jul 23, 2025